E-LIB Suche - Ergebnisse für: Spigel, D.

1

128P A phase I dose escalation and expansion trial of LYT-2..:

Falchook, G. ; Rasco, D. ; Papadopoulos, K....
Immuno-Oncology and Technology. 20 (2023) - p. 100600 , 2023

Link: https://doi.org/10.1016/..

2

PP01.50 EMERGE-201: Phase 2 Basket Study of Lurbinectedin M..:

Spigel, D. ; Galsky, M.D. ; Heeke, A.L....
Journal of Thoracic Oncology. 18 (2023) 3 - p. e31 , 2023

Link: https://doi.org/10.1016/..

3

EP06.03-16 Demographic and Genomic Characteristics of Non-S..:

Al-Obeidi, E. ; Williams, A. ; Burkert, N....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S489 , 2023

Link: https://doi.org/10.1016/..

4

P1.15-11 Durvalumab + Olaparib vs Durvalumab Alone as Maint..:

Ahn, M-j. ; Spigel, D. ; Bondarenko, I....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S124-S125 , 2022

Link: https://doi.org/10.1016/..

5

EP08.01-020 Phase 2 Platform Trial of Anti-TIGIT GSK'859A/E..:

Spigel, D. ; Lopez, P.G. ; Cheema, P....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S346 , 2022

Link: https://doi.org/10.1016/..

6

Five-year outcomes from the randomized, phase 3 trials Chec..:

Lind, M. ; Gettinger, S. ; Borghaei, H....
Lung Cancer. 139 (2020) - p. S49-S50 , 2020

Link: https://doi.org/10.1016/..

7

PACIFIC: Overall Survival with Durvalumab versus Placebo af..:

Raben, D. ; Faivre-Finn, C. ; Spigel, D....
International Journal of Radiation Oncology*Biology*Physics. 102 (2018) 5 - p. 1607-1608 , 2018

Link: https://doi.org/10.1016/..

8

7LBA Safety, activity, and response durability assessment o..:

Pietanza, M.C. ; Spigel, D. ; Bauer, T.M....
European Journal of Cancer. 51 (2015) - p. S712 , 2015

Link: https://doi.org/10.1016/..

9

41 Clinical activity of BIND-014 (docetaxel nanoparticles f..:

Natale, R. ; Socinski, M. ; Hart, L....
European Journal of Cancer. 50 (2014) - p. 19 , 2014

Link: https://doi.org/10.1016/..

10

Postfeminist nostalgia for a prefeminist future:

Spigel, L.
Screen. 54 (2013) 2 - p. 270-278 , 2013

Link: https://doi.org/10.1093/..

11

6132 POSTER Efficacy of Panitumumab Plus FOLFIRI Versus FOL..:

Price, T. ; Peeters, M. ; Strickland, A....
European Journal of Cancer. 47 (2011) - p. S431-S432 , 2011

Link: https://doi.org/10.1016/..

12

9073 POSTER Clinical Outcomes for Bevacizumab (BV)-treated ..:

Wozniak, A. ; Kosty, M.R. ; Jahanzeb, M....
European Journal of Cancer. 47 (2011) - p. S614 , 2011

Link: https://doi.org/10.1016/..

13

9121 Amrubicin monotherapy in patients with extensive disea..:

Ettinger, D.S. ; Jotte, R. ; Lorigan, P....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 541 , 2009

Link: https://doi.org/10.1016/..

14

9006 Safety of bevacizumab (BV) combined with chemotherapy ..:

Jahanzeb, M. ; Fischbach, N. ; Kosty, M....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 507 , 2009

Link: https://doi.org/10.1016/..

15

343 POSTER Phase I dose escalation study of the aurora kina..:

Burris, H.A. ; Hudes, G. ; Jones, S....
European Journal of Cancer Supplements. 4 (2006) 12 - p. 107 , 2006

Link: https://doi.org/10.1016/..